Wuhan COVID-19 Film Pulled in China Amid Public Backlash

BEIJING – A controversial film in China depicting the early days of the Wuhan COVID-19 lockdown has vanished from theaters. Distributors executed the abrupt cancellation on November 6, which marked the scheduled opening day. Public outcry and fierce online backlash forced studio executives to pull the highly anticipated drama.

The movie, officially titled Angel in White (白衣逆行者), disappeared suddenly from major Chinese movie-ticketing platforms like Maoyan. Platform administrators removed all screening schedules without issuing a formal public statement. The production team also abandoned all promotional efforts on their official social media channels.

Key Takeaways

Distributors pulled the Wuhan lockdown film Angel in White from all Chinese theaters on its scheduled release date.
Ticketing platforms deleted all screening times, while rating sites restricted user comments and pushed the release to 2027.
Fierce public backlash drove the cancellation, as citizens outright refused to revisit the traumatic memories of the COVID-19 era.

A Sudden Disappearance from Ticketing Platforms

Fans attempting to book tickets on Friday morning encountered blank pages across all major booking applications. Maoyan and Taopiaopiao entirely erased the film from their primary databases. This coordinated removal signals a definitive, unannounced withdrawal from the lucrative Chinese box office.

The popular movie-rating website Douban swiftly altered the film’s official release date to 2027. Administrators simultaneously locked the review section and restricted users from leaving new comments. These digital lockdowns often indicate highly sensitive political or social situations surrounding a major media release.

Producers maintained strict silence regarding the sudden theatrical schedule change. The official Angel in White Weibo account stopped posting promotional updates in late October. This sudden silence only fueled intense speculation among industry insiders and confused moviegoers.

Star-Studded Cast Fails to Save Pandemic Drama

Hong Kong filmmaker Herman Yau directed the ambitious project, bringing his signature high-stakes storytelling to the pandemic genre. The film stars cinematic icon Andy Lau alongside prominent mainland actress Yang Zishan. Industry analysts initially expected this powerhouse combination to guarantee a massive box office return.

The storyline follows ordinary residents and dedicated medical workers navigating the unprecedented public health crisis. Set in early 2020, the narrative highlights doctors, patients, and citizens helping one another survive. The script focuses heavily on emotional resilience during the initial viral outbreak.

Despite the immense star power, audiences immediately rejected the concept during the brief promotional period. The film wrapped production in December 2020 under the working title Epidemic Angels. Executives shelved the project for nearly six years before finally attempting this ill-fated November release.

Netizens Reject Traumatic Lockdown Memories

The sudden cancellation highlights a massive shift in Chinese public sentiment regarding pandemic narratives. When promoters announced the release date last month, Chinese social media platforms erupted with intense criticism. Many citizens openly expressed severe anger at the prospect of reliving the painful lockdown era.

Commenters on Weibo described the film as a desperate attempt to capitalize on national trauma. Users stated that the pandemic scars have barely healed and they refuse to tear them open again. Many Wuhan residents explicitly declared they would aggressively boycott the movie entirely.

“Nobody wants to remember those three years,” became a dominant rallying cry across major online forums. The rigid zero-COVID-19 policies left deep psychological impacts on the entire civilian population. Audiences now prefer escapist entertainment over grim reminders of sudden quarantines and widespread panic.

The Changing Landscape of Chinese Cinema

Early pandemic films enjoyed strong government support and generated moderate box office success. Movies like Chinese Doctors celebrated the heroic sacrifices of frontline medical staff members. However, the cultural appetite for these patriotic medical dramas has completely evaporated over time.

Box office analysts note that modern Chinese moviegoers heavily favor comedies, sci-fi spectacles, and lighthearted dramas. The traumatic realities of the recent past simply do not sell tickets in the current economic climate. Studios face massive financial risks when they greenlight massive projects tied to the pandemic.

Angel in White represents a highly costly miscalculation by out-of-touch studio executives. The six-year delay proved ultimately fatal to the film’s long-term commercial viability. By the time the final cut reached theaters, the target demographic had firmly moved on.

Future Prospects Remain Highly Uncertain

The indefinite delay leaves the financial future of Angel in White in serious jeopardy. Moving the release date to 2027 on Douban likely serves as a temporary placeholder measure. Industry experts strongly doubt the film will ever secure a wide theatrical release in mainland China.

Director Herman Yau and star Andy Lau maintain remarkably strong track records in the action thriller genre. Their previous cinematic collaborations consistently dominated the highly competitive Asian box office. This rare stumble highlights the unique volatility of producing socially relevant dramas in a sensitive market.

For now, the film exists only in brief, heavily edited trailer clips scattered across the internet. The complete cinematic vision of the Wuhan lockdown remains firmly locked away in studio vaults. Distributors must now decide whether to abandon the project entirely or attempt a quiet streaming release.